Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
B Chauffert, F Mornex, F Bonnetain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601
F Ferrand, D Malka, A Bourredjem, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
M Barhoumi, F Mornex, F Bonnetain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2008
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)
M Doffoël, F Bonnetain, O Bouché, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial
M Boulin, P Hillon, J P Cercueil, et al.
Gynecologie, Obstetrique & Fertilite
|
February 24, 2001
[Serum markers in breast cancer and colorectal cancer (1997)]
D Bellet, N Mlika-Cabanne, L Bedenne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
M Ychou, J-L Raoul, J-Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
T Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)
T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
B Chauffert, F Mornex, F Bonnetain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601
F Ferrand, D Malka, A Bourredjem, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
M Barhoumi, F Mornex, F Bonnetain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2008
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)
M Doffoël, F Bonnetain, O Bouché, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial
M Boulin, P Hillon, J P Cercueil, et al.
Gynecologie, Obstetrique & Fertilite
|
February 24, 2001
[Serum markers in breast cancer and colorectal cancer (1997)]
D Bellet, N Mlika-Cabanne, L Bedenne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
M Ychou, J-L Raoul, J-Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
T Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)
T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Page
of 9